Nuevos tratamientos contra el cáncer

Reglas del Foro
Este espacio únicamente pretende ser informativo, divulgativo y de opinión; y en ningún caso sustituir al criterio médico cualificado, ni sugerir o proporcionar terapias de ningún tipo.
Avatar de Usuario
Dalamar
Site Admin
Mensajes: 8831
Registrado: 09 May 2012 01:38

Re: Nuevos tratamientos contra el cáncer

Mensajepor Dalamar » 02 May 2016 04:41

Twenty-seven of 29 patients with an advanced type of leukemia that had proved resistant to multiple other forms of therapy went into remission after their T cells were genetically engineered to fight their cancers. The immune system is well-known for its remarkable ability to locate, recognize and attack invaders like the common cold. However, the immune system is not always able to eliminate cancer cells when they form. And once malignant tumors develop, they can use a variety of evasion tactics to outwit the immune system. This experimental therapy is designed to overcome some of these challenges, harnessing the power of the immune system to fight cancers by genetically engineering patients' T cells with a synthetic receptor molecule called a CAR (for chimeric antigen receptor) that empowers the T cells to recognize and kill cancer cells that bear a specific marker, called CD19.

This trial was designed to evaluate the safety of administering the engineered cells and to lay the groundwork for future improvements. It enrolled only adult patients with advanced disease that had relapsed or would not respond to other therapies. This paper includes data from 30 participants with B-cell acute lymphoblastic leukemia who received the cells. After patients' T cells were extracted from their bodies, a specialized virus delivered the DNA instructions for making the CAR into the cells. Then, the cells were multiplied to the billions in the lab. After chemotherapy, the now-reengineered cells were infused back into the patients they came from about two weeks after they were first extracted. This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer). With the assurance that each patient gets the same mixture of cells, the researchers were able to come to conclusions about the effects of administering different doses of cells.

In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Of the two participants who did not go into complete remission, one eventually reenrolled in the trial and went into complete remission after receiving a higher dose of cells. Not all patients stayed in complete remission: some relapsed and were treated again with CAR T cells, and two relapsed with leukemias that were immune to the CAR T cells. It is too early to know what the long-term outcomes of the cell therapy are. "It sounds fantastic to say that we get over 90 percent remissions, but there's so much more work to do make sure they're durable remissions, to work out who's going to benefit the most, and extend this work to other diseases."
¿Te ha gustado este hilo? Compartelo en las redes sociales para que se sume mas gente a la conversacion!

Avatar de Usuario
Dalamar
Site Admin
Mensajes: 8831
Registrado: 09 May 2012 01:38

Re: Nuevos tratamientos contra el cáncer

Mensajepor Dalamar » 19 Jun 2016 18:35

Fuente: http://www.pulseheadlines.com/scientist ... ase/36018/

Scientists discover memory loss reversal for Alzheimer’s

“The magnitude of improvement in these ten patients is unprecedented, providing additional objective evidence that this programmatic approach to cognitive decline is highly effective. “Even though we see the far-reaching implications of this success, we also realize that this is a slight study that needs to be replicated in larger numbers at various sites.”

With what they have found, researchers encourage people to be aware of APOE4 (genetic risk to contract Alzheimer) genetic status. If the disease is detected in time, there are techniques and methods modern medicine have guaranteed as proper solutions to Alzheimer patients.

65 percent of US Alzheimer cases involves APOE4 (primary genetic risk factor to develop Alzheimer). Former medical techniques avoided testing for APOE because it was thought that even if discovered, there was nothing to do to counteract it.

Each of the patients was given a personalized, 36-point program that included changes to diet, exercise, brain stimulation, sleep, vitamins and medications.
¿Te ha gustado este hilo? Compartelo en las redes sociales para que se sume mas gente a la conversacion!


Volver a “Salud”

cron

Ingresar